Search filters

List of works by Erin L Schenk

A Changing of the Guard: Immune Checkpoint Inhibitors With and Without Chemotherapy as First Line Treatment for Metastatic Non-small Cell Lung Cancer

CDK4/6 inhibition alone and in combination for non-small cell lung cancer

Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma

scientific article published on 16 March 2020

Effects of Selective Checkpoint Kinase 1 Inhibition on Cytarabine Cytotoxicity in Acute Myelogenous Leukemia Cells In Vitro ⬇️

scientific article published on August 6, 2012

HLA class I polymorphism has a dual impact on ligand binding and chaperone interaction.

scientific article

Local and systemic immunity predict survival in patients with pulmonary sarcomatoid carcinoma.

scientific article published on 15 July 2017

New Developments in Neoadjuvant Therapy for Lung Cancer

scientific article published on 01 March 2019

Phase I study of tanespimycin in combination with bortezomib in patients with advanced solid malignancies ⬇️

scientific article published on March 31, 2013

Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo

scientific article published on September 2008

Retraction: Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo

scientific article published in June 2010

The interface between tapasin and MHC class I: identification of amino acid residues in both proteins that influence their interaction

scientific article (publication date: 2002)

Tumor-intrinsic response to IFNγ shapes the tumor microenvironment and anti-PD-1 response in NSCLC

scientific article published on 27 May 2019

Paulina is supported by:

About Paulina

Help